Kumar N - Search Results

1

Elicitation of potent serum neutralizing antibody responses in rabbits by immunization with an HIV-1 clade C trimeric Env derived from an Indian elite neutralizer.

Kumar R, Deshpande S, Sewall LM, Ozorowski G, Cottrell CA, Lee WH, Holden LG, Richey ST, Chandrawacar AS, Dhiman K, Ashish, Kumar V, Ahmed S, Hingankar N, Kumar N, Murugavel KG, Srikrishnan AK, Sok D, Ward AB, Bhattacharya J. Kumar R, et al. Among authors: kumar v, kumar n. PLoS Pathog. 2021 Apr 7;17(4):e1008977. doi: 10.1371/journal.ppat.1008977. eCollection 2021 Apr. PLoS Pathog. 2021. PMID: 33826683 Free PMC article.

2

Stabilization of a soluble, native-like trimeric form of an efficiently cleaved Indian HIV-1 clade C envelope glycoprotein.

Ahmed S, Shrivastava T, Kumar N, Ozorowski G, Ward AB, Chakrabarti BK. Ahmed S, et al. Among authors: kumar n. J Biol Chem. 2017 May 19;292(20):8236-8243. doi: 10.1074/jbc.M117.776419. Epub 2017 Mar 10. J Biol Chem. 2017. PMID: 28283570 Free PMC article.

3

Envelope proteins of two HIV-1 clades induced different epitope-specific antibody response.

Shrivastava T, Samal S, Tyagi AK, Goswami S, Kumar N, Ozorowski G, Ward AB, Chakrabarti BK. Shrivastava T, et al. Among authors: kumar n. Vaccine. 2018 Mar 14;36(12):1627-1636. doi: 10.1016/j.vaccine.2018.01.081. Epub 2018 Feb 9. Vaccine. 2018. PMID: 29429810

4

Design and characterization of a germ-line targeting soluble, native-like, trimeric HIV-1 Env lacking key glycans from the V1V2-loop.

Ahmed S, Shrivastava T, Kumar R, Kumar M, Banerjee M, Kumar N, Bansal M, Das S, Samal S. Ahmed S, et al. Among authors: kumar r, kumar n, kumar m. Biochim Biophys Acta Gen Subj. 2021 Jan;1865(1):129733. doi: 10.1016/j.bbagen.2020.129733. Epub 2020 Sep 16. Biochim Biophys Acta Gen Subj. 2021. PMID: 32949621

5

Cell surface ectodomain integrity of a subset of functional HIV-1 envelopes is dependent on a conserved hydrophilic domain containing region in their C-terminal tail.

Samal S, Das S, Boliar S, Qureshi H, Shrivastava T, Kumar N, Goswami S, Bansal M, Chakrabarti BK. Samal S, et al. Among authors: kumar n. Retrovirology. 2018 Jul 20;15(1):50. doi: 10.1186/s12977-018-0431-4. Retrovirology. 2018. PMID: 30029604 Free PMC article.

6

Chlorambucil Conjugation Enhances the Potency of Rituximab: Synthesis and Evaluation of the Novel [¹⁷⁷Lu]Lu-Labeled Rituximab-Chlorambucil Conjugate toward Therapy of Non-Hodgkin's Lymphoma.

Kumar N, Suman SK, Guleria M, Kolay S, Amirdhanayagam J, Chakraborty A, Rakshit S, Mukherjee A, Das T. Kumar N, et al. J Med Chem. 2025 Jan 14. doi: 10.1021/acs.jmedchem.4c01954. Online ahead of print. J Med Chem. 2025. PMID: 39807673

7

A Critical Appraisal of the Application of Frailty and Sarcopenia in the Spinal Oncology Population.

MacLean MA, Charles AJ, Georgiopoulos M, Phinney J, Charest-Morin R, Goodwin R, Laufer I, Fehlings MG, Shin J, Dea N, Rhines LD, Sahgal A, Gokaslan Z, Stephens B, Disch AC, Kumar N, O'Toole J, Sciubba DM, Netzer C, Goldschlager T, Gibbs W, Weber MH; AO Spine Knowledge Forum Tumor. MacLean MA, et al. Among authors: kumar n. Global Spine J. 2025 Jan;15(1_suppl):47S-80S. doi: 10.1177/21925682231207325. Global Spine J. 2025. PMID: 39801122 Free article.

8

Role of Posterior Carbon Fiber Implants in Spine Tumor Surgery.

Alvarez-Breckenridge CA, North R, Tatsui C, Kumar N, Lo SF, Mohammed K, Reynolds J, Lazary A, Laufer I, Verlaan JJ, Gokaslan Z, Luzzati A, Cecchinato R, Shin J, Hornicek F, Disch A, Goodwin M, Goodwin R, Sahgal A, Gasbarrini A, Boriani S. Alvarez-Breckenridge CA, et al. Among authors: kumar n. Global Spine J. 2025 Jan;15(1_suppl):157S-165S. doi: 10.1177/21925682241259778. Global Spine J. 2025. PMID: 39801115 Free PMC article.

9

Correlation between sarcopenia and hypertrophy of the future liver remnant in patients undergoing portal vein embolization before liver resection.

Baby A, Patidar Y, Mukund A, Srivastava A, Kumar N, Sasturkar SV, Tevethia HV, Pamecha V. Baby A, et al. Among authors: kumar n. Br J Radiol. 2025 Jan 12:tqaf003. doi: 10.1093/bjr/tqaf003. Online ahead of print. Br J Radiol. 2025. PMID: 39799514

10

In vitro and in vivo Investigations of 4-Substituted 2-Phenylquinazoline derivatives as multipotent ligands for the treatment of Alzheimer's disease.

Kumar V, Jangid K, Kumar V, Kumar N, Mishra J, Arora T, Dwivedi AR, Kumar P, Bhatti JS, Parkash J, Kumar V. Kumar V, et al. Among authors: kumar n. Bioorg Chem. 2025 Jan 3;155:108126. doi: 10.1016/j.bioorg.2025.108126. Online ahead of print. Bioorg Chem. 2025. PMID: 39798452

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

9,405 results

Search Page

Filters